Gross Profit Summary of GenMont Biotech Incorporation

GenMont Biotech Incorporation's latest annual gross profit in 2023 was 177.33 Million TWD , down -30.92% from previous year.
GenMont Biotech Incorporation's latest quarterly gross profit in 2024 Q2 was 50.98 Million TWD , down -27.54% from previous quarter.
GenMont Biotech Incorporation reported a annual gross profit of 256.71 Million TWD in annual gross profit 2022, down -14.23% from previous year.
GenMont Biotech Incorporation reported a annual gross profit of 299.32 Million TWD in annual gross profit 2021, up 38.97% from previous year.
GenMont Biotech Incorporation reported a quarterly gross profit of 50.98 Million TWD for 2024 Q2, down -27.54% from previous quarter.
GenMont Biotech Incorporation reported a quarterly gross profit of 55.46 Million TWD for 2023 Q2, up 3.91% from previous quarter.

Annual Gross Profit Chart of GenMont Biotech Incorporation (2023 - 2009)

Historical Annual Gross Profit of GenMont Biotech Incorporation (2023 - 2009)

Year	Gross Profit	Gross Profit Growth
2023	177.33 Million TWD	-30.92%
2022	256.71 Million TWD	-14.23%
2021	299.32 Million TWD	38.97%
2020	215.39 Million TWD	-6.23%
2019	229.7 Million TWD	-17.24%
2018	277.54 Million TWD	-13.72%
2017	321.67 Million TWD	3.74%
2016	310.08 Million TWD	13.47%
2015	273.28 Million TWD	7.87%
2014	253.35 Million TWD	18.37%
2013	214.03 Million TWD	48.48%
2012	144.14 Million TWD	-24.84%
2011	191.77 Million TWD	-51.26%
2010	393.43 Million TWD	39.42%
2009	282.19 Million TWD	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q1	70.36 Million TWD	60.22%
2024 Q2	50.98 Million TWD	-27.54%
2023 Q2	55.46 Million TWD	3.91%
2023 Q3	49.82 Million TWD	-10.17%
2023 FY	177.33 Million TWD	-30.92%
2023 Q4	43.91 Million TWD	-11.86%
2023 Q1	53.37 Million TWD	-30.05%
2022 Q4	76.31 Million TWD	53.34%
2022 FY	256.71 Million TWD	-14.23%
2022 Q3	49.76 Million TWD	-27.53%
2022 Q2	68.67 Million TWD	10.82%
2022 Q1	61.96 Million TWD	-26.47%
2021 Q1	73.57 Million TWD	33.58%
2021 FY	299.32 Million TWD	38.97%
2021 Q4	84.27 Million TWD	11.44%
2021 Q3	75.62 Million TWD	14.84%
2021 Q2	65.85 Million TWD	-10.49%
2020 Q1	53.78 Million TWD	13.04%
2020 Q2	49.47 Million TWD	-8.0%
2020 Q3	57.04 Million TWD	15.3%
2020 FY	215.39 Million TWD	-6.23%
2020 Q4	55.07 Million TWD	-3.45%
2019 FY	229.7 Million TWD	-17.24%
2019 Q1	60.91 Million TWD	-6.62%
2019 Q3	63.05 Million TWD	8.42%
2019 Q2	58.15 Million TWD	-4.52%
2019 Q4	47.57 Million TWD	-24.54%
2018 Q1	76.72 Million TWD	28.46%
2018 FY	277.54 Million TWD	-13.72%
2018 Q4	65.22 Million TWD	-18.19%
2018 Q3	79.73 Million TWD	17.22%
2018 Q2	68.01 Million TWD	-11.35%
2017 Q2	83.93 Million TWD	9.02%
2017 FY	321.67 Million TWD	3.74%
2017 Q4	59.72 Million TWD	-40.88%
2017 Q3	101.01 Million TWD	20.35%
2017 Q1	76.99 Million TWD	11.18%
2016 FY	310.08 Million TWD	13.47%
2016 Q4	69.24 Million TWD	-7.72%
2016 Q3	75.04 Million TWD	-16.39%
2016 Q2	89.75 Million TWD	18.04%
2016 Q1	76.03 Million TWD	21.45%
2015 FY	273.28 Million TWD	7.87%
2015 Q1	56.27 Million TWD	30.87%
2015 Q2	59.2 Million TWD	5.2%
2015 Q3	95.19 Million TWD	60.78%
2015 Q4	62.6 Million TWD	-34.23%
2014 FY	253.35 Million TWD	18.37%
2014 Q3	63.13 Million TWD	-19.5%
2014 Q1	68.78 Million TWD	46.55%
2014 Q4	43 Million TWD	-31.88%
2014 Q2	78.43 Million TWD	14.03%
2013 Q4	46.93 Million TWD	-1.47%
2013 FY	214.03 Million TWD	48.48%
2013 Q2	64.71 Million TWD	18.19%
2013 Q1	54.75 Million TWD	40.77%
2013 Q3	47.63 Million TWD	-26.39%
2012 Q4	38.89 Million TWD	17.05%
2012 Q2	41.85 Million TWD	38.77%
2012 Q1	30.16 Million TWD	-51.13%
2012 Q3	33.23 Million TWD	-20.61%
2012 FY	144.14 Million TWD	-24.84%
2011 Q2	31.04 Million TWD	-55.55%
2011 Q1	69.83 Million TWD	-36.55%
2011 FY	191.77 Million TWD	-51.26%
2011 Q4	61.71 Million TWD	111.5%
2011 Q3	29.18 Million TWD	-5.99%
2010 Q2	99.07 Million TWD	-3.92%
2010 Q1	103.11 Million TWD	0.0%
2010 FY	393.43 Million TWD	39.42%
2010 Q4	110.07 Million TWD	35.59%
2010 Q3	81.18 Million TWD	-18.06%
2009 FY	282.19 Million TWD	0.0%

Peer Gross Profit Comparison of GenMont Biotech Incorporation

Name	Gross Profit	Gross Profit Difference
Apex Biotechnology Corp.	531.11 Million TWD	66.611%
Sinphar Pharmaceutical Co.,Ltd.	1.09 Billion TWD	83.749%
Panion & Bf Biotech Inc.	912.56 Million TWD	80.567%
Chunghwa Chemical Synthesis & Biotech Co., Ltd.	757.3 Million TWD	76.583%
Abnova (Taiwan) Corporation	173.91 Million TWD	-1.967%
Adimmune Corporation	410.93 Million TWD	56.846%
Tanvex BioPharma, Inc.	59.7 Million TWD	-197.04%
Polaris Group	-137.9 Million TWD	228.597%
Energenesis Biomedical CO.,LTD.	5.22 Million TWD	-3292.692%
UnicoCell Biomed Co., Ltd.	17.89 Million TWD	-890.87%
PELL Bio-Med Technology Co. Ltd.	-26.14 Million TWD	778.409%

Global Stocks Search

GenMont Biotech Incorporation (3164.TW)

Gross Profit Summary of GenMont Biotech Incorporation

Annual Gross Profit Chart of GenMont Biotech Incorporation (2023 - 2009)

Historical Annual Gross Profit of GenMont Biotech Incorporation (2023 - 2009)

Peer Gross Profit Comparison of GenMont Biotech Incorporation